FasL expression by solid tumors promotes tumor metastasis17 and immune evasion.18 FasL is overexpressed in ovarian tumor vasculature12 and has higher expression in the ovarian TME than in normal ovarian tissue.19 We evaluated the distribution of FasL expression in high-grade serous ovarian cancer. Here, FASLG is linked to ovarian serous adenocarcinoma.